Work

PLANETTE: A modular phase IIa multicenter open-label study evaluating the ATR inhibitor ceralasertib (AZD6738) in ATM mutant advanced solid tumors.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.6_suppl.tps189

Authors: Wassim Abida, Elkhan Sanay, Natalia Lukashchuk, Andrew Pierce, Wessel de Graaf, Alan Lau, Vidalba Rocher Ros, Nisha Kurian, Graeme Parr, Bienvenu LoembE, Emma Dean, Rahul Raj Aggarwal

Institutions: Memorial Sloan Kettering Cancer Center, AstraZeneca (United Kingdom), University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3135007917

Cites:

Cited by: 3

Related to: 10